drugset / Trial / NCT00135122

Prednisolone in the Treatment of Withdrawal Headache in Probable Medication Overuse Headache

NCT00135122 ↗

Phase 3 Completed 100 enrolled Sorlandet Hospital HF
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether prednisolone is more effective than placebo in the first six days after initiation of medication withdrawal therapy for a medication overuse headache. Another purpose is to study whether patients followed by a neurologist 1 year after withdrawal do better than patients followed by a general practitioner.

Timeline

Start
2003-09
Primary completion
2007-01
Completion
2007-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Prednisolone Other / unclassified 20 mg Oral

Indications